The key objectives of this evaluation were to: (1) Evaluate whether the IOM Committee has met the requirements and needs of CDC and NIH as described in the original scope of work and by informed agency staff members; (2) Assess the knowledge of the IOM Committee and its reports by various external partners and stakeholder groups; (3) Assess the impact of the IOM reports on immunization decisions of vaccine recipients and/or their parents; (4) Assess the impact of the IOM reports on information relayed to vaccine recipients or their patients by their health care providers. The methods consisted of primary (in-depth key informant surveys and interviews) and secondary (abstractions of IOM Committee reports to evaluate whether the Committee met its scope of work) data analysis. The analysis concluded that the IOM Committee generally met the scope of work, but there were incidents in which the Committee appeared to exceed or fail to meet the mission set out for it. There is a clear consensus that a continuing need exists for a credible vaccine safety review group. However, there is no consensus on the membership or structure of such a group.
PIC ID: 7986; Agency Sponsor: CDC, Centers for Disease Control and Prevention; Federal Contact: Dietz, Sue, 404-639-0210; Performer: Research Triangle Institute, Research Triangle Park, NC